J.Safra Asset Management Corp Merus N.V. Call Options Transaction History
J.Safra Asset Management Corp
- $1.54 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MRUS
# of Institutions
223Shares Held
65.3MCall Options Held
311KPut Options Held
556K-
Paradigm Biocapital Advisors LP New York, NY4.28MShares$407 Million10.51% of portfolio
-
Rtw Investments, LP New York, NY4MShares$380 Million3.23% of portfolio
-
Wellington Management Group LLP Boston, MA3.73MShares$354 Million0.04% of portfolio
-
Commodore Capital LP New York, NY3.53MShares$335 Million17.29% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$322 Million4.09% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $4.36B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...